KPIs & Operating Metrics(New)
Adjusted Ebitda By SegmentAdjusted Ebitda By Segment AnnualAdjusted Ebitda Margin By Segment %Adjusted Ebitda Margin By Segment Annual %Average Pmpm By Product TypeAverage Pmpm Fees / Revenue Per Case By SegmentAverage Unique MembersAverage Unique Members AnnualAverage Yield Per CaseBreakdown Of AssetsContractual ObligationsCost Of RevenueDeferred RevenueEmployee StatisticsGross Margin %Gross ProfitIncome (Loss) Before Income Tax By RegionLives By Product TypeLives Managed By SegmentLives On Platform/ Cases During Period By SegmentNon Gaap ProfitabilityNon Gaap Profitability %Non Gaap Profitability AnnualNon Gaap Profitability Annual %Opex As A % Of Total Revenue %OPEX SegregationProperty And Equipment, NetRemaining Performance ObligationsRemaining Performance Obligations AnnualRevenue By Business VerticalRevenue By Business Vertical %Revenue By Business Vertical AnnualRevenue By Business Vertical Annual %Revenue By End MarketRevenue By End Market %Revenue By End Market AnnualRevenue By End Market Annual %Revenue By Product TypeRevenue By Product Type %Revenue By Product Type AnnualRevenue By Product Type Annual %Revenue By SegmentRevenue By Segment %Revenue By Segment AnnualRevenue By Segment Annual %Total Cases ManagedTotal Lives ManagedTotal Lives On Platform
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Evolent Health (EVH) Gross Profit (2016 - 2025)

Historic Gross Profit for Evolent Health (EVH) over the last 11 years, with Q3 2025 value amounting to $99.8 million.

  • Evolent Health's Gross Profit rose 2364.64% to $99.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $378.3 million, marking a year-over-year decrease of 379.59%. This contributed to the annual value of $367.4 million for FY2024, which is 2022.22% down from last year.
  • Latest data reveals that Evolent Health reported Gross Profit of $99.8 million as of Q3 2025, which was up 2364.64% from $100.4 million recorded in Q2 2025.
  • In the past 5 years, Evolent Health's Gross Profit ranged from a high of $124.4 million in Q3 2023 and a low of $49.9 million during Q2 2021
  • For the 5-year period, Evolent Health's Gross Profit averaged around $89.3 million, with its median value being $86.0 million (2022).
  • As far as peak fluctuations go, Evolent Health's Gross Profit surged by 6686.79% in 2023, and later plummeted by 3514.99% in 2024.
  • Quarter analysis of 5 years shows Evolent Health's Gross Profit stood at $83.9 million in 2021, then decreased by 0.97% to $83.1 million in 2022, then increased by 22.35% to $101.6 million in 2023, then fell by 25.5% to $75.7 million in 2024, then soared by 31.78% to $99.8 million in 2025.
  • Its Gross Profit stands at $99.8 million for Q3 2025, versus $100.4 million for Q2 2025 and $102.5 million for Q1 2025.